Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

  1. De Lago, E.
  2. Moreno-Martet, M.
  3. Cabranes, A.
  4. Ramos, J.A.
  5. Fernández-Ruiz, J.
Aldizkaria:
Neuropharmacology

ISSN: 1873-7064,  0028-3908

Argitalpen urtea: 2012

Alea: 62

Zenbakia: 7

Orrialdeak: 2299-2308

Mota: Artikulua

DOI: 10.1016/J.NEUROPHARM.2012.01.030 GOOGLE SCHOLAR
Datuen iturria: Scopus